The effect of a unique propolis compound (Propoelix™) on clinical outcomes in patients with dengue hemorrhagic fever.

Infect Drug Resist · 2014 · PMC4266269 · PMID 25525372

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Platelet counts in the PropoelixTM-treated group showed a trend toward a faster recovery by day 3 of admission and became statistically significant by day 6 (101.42±48.79 vs 80.78±43.35 [10 3 /mL], P =0.042) and day 7 (146.67±64.68 vs 107.84±57.22 [10 3 /mL], P =0.006).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.